Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review-Reference-Cited by-同舟云学术

Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review

Published:2017-02-17 Issue:19 Volume:8 Page:31318-31328
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cai Xiu-Rong¹²,Li Xing¹²,Lin Jin-Xiang¹,Wang Tian-Tian¹²,Dong Min¹²,Chen Zhan-Hong¹²,Jia Chang-Chang²³,Hong Ying-Fen¹²,Lin Qu¹²,Wu Xiang-Yuan¹²

Affiliation:

1. Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, People's Republic of China

2. Guangdong provincial Key Laboratory of Liver Disease Research, Guangzhou 510630, People's Republic of China

3. Cell-gene Therapy Translational Medicine Research Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, People's Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome;Biomedicine & Pharmacotherapy;2023-09

2. Hepatocellular Carcinoma: A Review;Asian Journal of Research in Pharmaceutical Sciences;2023-05-22

3. Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma;Bioscience Reports;2022-02

4. Targets of immunotherapy for hepatocellular carcinoma: An update;World Journal of Hepatology;2022-01-27

5. Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases;OncoTargets and Therapy;2021-12